Physician
Hematology
Dr. Luke P. Akard, MD
|
|
Give Review
Dr. Luke P. Akard practices Hematology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care Dr. Luke P. Akard has written publications. He has 58 publications published with PubMed. The lastest publication is: 'Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes.' Luke Akard accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
- Barriers to Physician Adherence to Evidence-Based Monitoring Guidelines in Chronic Myelogenous Leukemia.
- Omacetaxine mepesuccinate in patients with advanced chronic myeloid Leukemia with resistance or intolerance to tyrosine kinase inhibitors.
- Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid Leukemia: Results with 24 months ...
- Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid Leukemia previously treated with 2 or more tyrosine kinase inhibitors including i...
- Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners.
- Second-generation BCR-ABL kinase inhibitors in CML.
- Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster enGraftment without...
- Prediction of enGraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
- Hypereosinophilic Syndrome: long-term remission following allogeneic stem cell transplant in spite of transient eosinophilia post-transplant.
- Peripheral blood progenitor Cell transplantation.
- Regulation of neutrophil responses by phosphotyrosine phosphatase.
- Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
- Parallel up-regulation of CD11B and CD45 on neutrophilic leukocytes exposed to soluble factors of oral pathogens.
- Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of Graft-versus-host disease after allogeneic bone marrow transplantation.
- Identification of type-2 phosphatidic acid phosphohydrolase (PAPH-2) in neutrophil plasma membranes.
- Immunomagnetic CD8 depletion.
- Cytokine-stimulated up-regulation of protein tyrosine phosphatase in neutrophil plasma membranes.
- Phorbol ester-induced priming of superoxide generation by phosphatidic acid-stimulated neutrophils and granule-free neutrophil cytoplasts.
- Maturation of mobilized peripheral blood progenitor Cells: preclinical and phase I clinical studies.
- Dose-intensive chemotherapy in refractory germ cell Cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
- Treatment of refractory Lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation.
- Characteristics of enGraftment after repeated autologous bone marrow transplantation.
- Immunomagnetic depletion of CD8+ lymphocytes from marrow Grafts.
- Counterflow centrifugal elutriation as a method of T Cell depletion may cause loss of immature CD34+ Cells.
- Differences in CD34+ Cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
- Comparison of the distribution of progenitor Cells in G-CSF-mobilized peripheral blood and steady-state bone marrow after counterflow centrifugal elutriation.
- Induction of apoptosis by arachidonic acid in chronic myeloid Leukemia cells.
- Lineage commitment of HLA-DR/CD38-defined progenitor Cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
- Optimum methods to mobilize stem Cells.
- Longitudinal study of adaptation to the stress of bone marrow transplantation.
- Matched-pair analysis of hematopoietic progenitor Cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: enhanced CD34+ Cell collections are not nec...
- Characterization and purification of neutrophil ecto-phosphatidic acid phosphohydrolase.
- Hematopoietic growth factor after autologous Peripheral blood transplantation: comparison of G-CSF and GM-CSF.
- Characterization and partial purification of CD34+ progenitor Cell ecto-phosphatidic acid phosphohydrolase.
- Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes.
- Impaired stem Cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF.
- Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe Acute GVHD.
- Growth factor induction of cytosolic protein tyrosine kinase activity in human haemopoietic progenitor Cells isolated by flow cytometry.
- Cytosolic inactivation of translocated neutrophil plasma membrane protein tyrosine phosphatase.
- Successful allogeneic bone marrow transplantation in an adult with aplastic Anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
- Gp-regulated phosphoinositide hydrolysis in turkey and human erythrocytes exposed to fluoride ion: relationship to calcium influx.
- Alpha-interferon and immune hemolytic Anemia.
- Chronic T cell lymphoproliferative disorder and pure red cell aplasia. Further characterization of cell-mediated inhibition of erythropoiesis and clinical response to ...
- Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor.
- Cell-free activation of phagocyte NADPH-oxidase: tissue and differentiation-specific expression of cytosolic cofactor activity.
- Regulation of neutrophil NADPH oxidase activation in a cell-free System by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxi...
- Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement by newly activated enzyme sustains the respiratory burst.
- Semiautomated processing of bone marrow Grafts for transplantation.
- Slow platelet recovery after PBPC transplantation from unrelated donors.
- High-dose imatinib in newly diagnosed chronic-phase chronic myeloid Leukemia: high rates of rapid cytogenetic and molecular responses.
- Utility of single versus tandem autotransplants for advanced testes/germ cell Cancer: a center for international blood and marrow transplant research (CIBMTR) analysis.
- Delayed ABLC prophylaxis after allogeneic stem-Cell transplantation.
- Transplantation of hematopoietic stem Cells from the peripheral blood.
- Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem Cell transplantation.
- Transportation of peripheral blood progenitor Cell products: effect of ambient temperature.
- Transportation of peripheral blood progenitor Cell products: effects of time, temperature and Cell concentration.
Schools
Indiana University School Of Medicine
Clarian Indiana University Hospital
Clarian Methodist Hospital Of Indi
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Managed Care (Non-HMO)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Pipefitters
- Principal Life
- Pyramid Life
- Sagamore Plus
- Saint Francis Health Network
- Tricare
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1780798660 | |
| NPPES Provider LastName | AKARD | |
| NPPES Provider FirstName | LUKE | |
| NPPES Provider ZIPCode | 462378601 | |
| NPPES Provider State | IN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 498.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 2.21 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780798660 |
| Last Name Of The Provider | AKARD |
| First Name Of The Provider | LUKE |
| View All |
Similar Doctors
|
|
Dr. Anita R. Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Thompson, DO |
|
|
Dr. Jan Jansen, MD |
|
|
Dr. Michael J. Dugan, MD
This Doctor is OpenDoctor Recommended.
|